Latest in Research & Development

Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target

BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target

Find out more

FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing

A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with...
See more

Neuland Laboratories to partner with LIR Life Sciences for transdermal GLP-1 development

The pair will work to advance LIR Life's novel cell-penetrating peptides for next-generation obesity therapies, looking to improve patient adherence and broaden access

Hongene to support SiranBio siRNA candidate programme with CDMO services

The RNA specialist will support SiranBio's SA1211 programme, helping advance the siRNA candidate through its vertically integrated CDMO services to address the complex nature of the next-gen therapeutic

BioDuro and CTI Technology partner to push forward preclinical drug development

The duo will combine their manufacturing experience and analytical capabilities to build an integrated platform spanning all the way from drug discovery to IND submission to accelerate the drug development path for clients

Scientists develop new technique to fight antimicrobial resistance

The team of researchers from the University of Leicester have developed a new technique to sequence phage genomes from individual plaques and hopes to use it to build fully characterised libraries of bacteriophages, expanding the number of candidates available to tackle drug-resistant infections

Lancet Oncology Commission launches to examine future of academic cancer clinical trials amid funding and regulatory pressures

A global coalition of clinical investigators and patient representatives has launched the Lancet Oncology Commission to address the value and challenges of independent academic cancer clinical trials, amid growing concerns over regulatory complexity, limited public funding and the need for new international collaboration models
You need to be a subscriber to read this article.
Click here to find out more.

UK clinical trial reforms come into force in largest regulatory overhaul in 20 years

The MHRA and Health Research Authority are implementing the most significant package of clinical trial regulatory reforms in more than two decades, introducing faster assessment routes for lower-risk trials and mandatory registration of trial results

Epitopea receives MHRA approval for first-in-human trial of RNA vaccine for ovarian cancer

The company has received regulatory approval from the MHRA and Regional Ethics Committee to initiate its OVACT Phase I/Ib clinical trial of CryptiVax-1001, an off-the-shelf mRNA immunotherapy targeting high-grade serous ovarian cancer

From lab to launch: transforming pharmaceutical formulation development with GEA’s CFC Lab Coater

A new generation of continuous film coating technology is giving R&D teams the speed, precision and scalability they need to take products from the laboratory to commercial production without the traditional bottlenecks

Latest posts in Research & Development

NEUVIOR Pharmaceuticals receives Innovate UK grant to explore bio-based materials for circular pharmaceutical manufacturing

The Innovate UK feasibility grant will advance its ZYLON programme, which involves clean-chemistry lab trials exploring how bio-derived materials could replace harder-to-recycle packaging formats and reduce waste in pharmaceutical manufacturing

Awen Oncology secures seven-figure funding to advance rare bone cancer therapeutic programme

The cancer therapeutics company has secured seven-figure funding led by biotech investor Dr Urs Spitz to progress its lead programme targeting a rare form of bone cancer with potential broader oncology applications towards clinical development

Leinco Technologies and CellCarta partner to advance proteomics solutions for discovery and drug development

The pair have announced a strategic collaboration combining Leinco's IHC and spatial biology-validated antibody portfolio with CellCarta's CPTAC-validated Immuno-MRM assay resources to enhance proteomic analysis for immuno-oncology and targeted therapy development

Biognosys collaborates with Michael J. Fox Foundation to develop biomarker assays for Parkinson's research

The pair will work to develop highly sensitive, quantitative biomarker assays targeting LRRK2, the most common genetic risk factor for late-onset Parkinson's disease, in support of the foundation's global LITE initiative spanning more than 50 academic, industry and clinical partners

AstraZeneca's tozorakimab succeeds in third pivotal Phase III COPD trial

The positive results have shown that tozorakimab significantly reduced moderate-to-severe COPD exacerbations, adding to the earlier positive results from the OBERON and TITANIA trials and further supporting its potential as a first-in-class IL-33-targeting biologic

CelLBxHealth and Royal Marsden to study CTC-DNA profiling in advanced lung cancer patients

The company announced a translational clinical collaboration with The Royal Marsden NHS Foundation Trust to analyse circulating tumour cell DNA in 200 advanced non-small cell lung cancer patients whose standard ctDNA liquid biopsy testing fails to identify actionable genomic mutations

Roche launches global Phase III Elevidys trial to support EU approval for Duchenne gene therapy

Roche has initiated a new Phase III study of Elevidys, aiming to generate placebo-controlled data for European Medicines Agency resubmission and expand access to the Duchenne muscular dystrophy gene therapy

"Miracle" Alzheimer's drugs show no meaningful benefit, says major review

Amyloid-clearing drugs hailed as a breakthrough for Alzheimer's treatment make "no meaningful difference to patients" and increase the risk of brain swelling and bleeding, according to a sweeping new Cochrane meta-analysis

Amazon rolls out AI-powered platform Amazon Bio Discovery for drug discovery

The new application will assist with drug design, allowing more researchers to access leading AI models rather than just those with AI and coding skills. Already in use with partners such as MSK, the platform has reduced the timeline for antibody design for potential pediatric cancer therapies from months to weeks

Aragen launches ChemiSHE, India's first women-led chemistry synthesis laboratory

The firm has inaugurated ChemiSHE, a pioneering all-women chemistry synthesis laboratory at its Hyderabad campus, as part of a broader diversity initiative targeting the addition of up to 1000 women employees across scientific and leadership roles during the next three years

Chemify founder publishes three papers validating Chemputation platform for automated drug discovery

Lee Cronin, CEO of deep-tech company Chemify, has published three papers in PNAS, Nature Communications Chemistry and Nature Communications Biology, demonstrating how Chemputation can digitise chemistry

Sponsor content

From lab to launch: transforming pharmaceutical formulation development with GEA’s CFC Lab Coater

A new generation of continuous film coating technology is giving R&D teams the speed, precision and scalability they need to take products from the laboratory to...

Precision meets innovation in melting point determination

Advancing analytical accuracy with automated thermal analysis

Ion chromatography in pharmaceutical analysis: a long road to acceptance

John Welch, Associate Director, Butterworth Laboratories, writes on how ion chromatography evolved into a mature and widely adopted pharmaceutical analysis technique

Implementing compendial methods to minimise testing risk

Understanding feasibility testing and verification to ensure reliable analytical results

Visit Butterworth Laboratories at making pharmaceuticals 2026

Meet the team to discuss analytical testing and development support

Why patient voices matter in rare disease innovation

Patient advocacy event highlights the role of collaboration and lived experience in advancing rare disease treatments

L.B. Bohle hosts successful continuous manufacturing workshop in Brazil

Focus on continuous wet granulation and drying for research, development and small-scale production

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development

Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development

Degasser for volatile and aggressive solvents

Biotech Fluidics announce the DEGASi Integration HFIP - a high-performance online system designed to efficiently degas even the toughest solvents. This unique...

Evaporation and lyophilization for converting RP-HPLC peptide fractions into stable powders

A method to obtain research peptides in a stable, dry, and contamination-free form for long-term storage

New ion chromatograph enhances water quality testing efficiency

Shimadzu’s Nexera IC combines automation and intuitive software to support reliable ion analysis and reduce laboratory workload

TurboFil debuts latest generation of through-the-tip benchtop syringe filler

TipFil Plus provides precise, aseptic-ready filling and capping for lab and pharmacy applications

Featured companies

As a dedicated CDMO serving the healthcare industry, we bring life-enhancing and life-saving treatments to market for our customers and their patients. We are a pioneer and... PCI Pharma Services: Your bridge between life-changing therapies and patients. 3P innovation is a UK-based engineering and custom automation company, delivering innovative solutions to leading major pharmaceutical and medical device companies. We support... At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable.
See more